Qubis
To add a bio or update investment portfolio, please click update information.
Investment Portfolio


AMPLY
1 May 2025
AMPLY raises £1.3m seed led by Twin Path Ventures to accelerate drug discovery for aggressive cancers and superbugs
AMPLY builds an AI driven drug discovery platform that combines computational biology, sequencing and lab validation to develop new treatments for aggressive cancers and drug resistant infections.


StimOxyGen
11 Mar 2025
StimOxyGen raises £1.5m seed led by DSW Ventures to advance oxygen-based cancer therapy
StimOxyGen develops oxygen delivery therapies designed to improve tumour response to radiotherapy and immunotherapy by addressing hypoxia in solid cancers, initially focusing on pancreatic cancer.
More venture news
- 4 Sept 2026

AI ScoreAI Score lands a £4m seed round led by Fuel Ventures to track and control AI usage within organisations
SeedAI - 2 Sept 2026

Ki 13Ki 13 unlocks a £3.7m seed round led by HICO Investment Group to make green hydrogen and CO₂ from biomass
SeedEnergy - 1 Sept 2026

OrchestraOrchestra lands a £2.4m seed round led by Differential Ventures for control plane that runs data pipelines and AI agents together
SeedDeveloper Tools